| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 440 | 2021 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 128 | 2022 |
| Previous SARS-CoV-2 infection, age, and frailty are associated with 6-month vaccine-induced anti-spike antibody titer in nursing home residents AH Dyer, C Noonan, M McElheron, I Batten, C Reddy, E Connolly, ... Journal of the American Medical Directors Association 23 (3), 434-439, 2022 | 29 | 2022 |
| Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination L Garcia, T Woudenberg, J Rosado, AH Dyer, F Donnadieu, D Planas, ... Viruses 14 (7), 1491, 2022 | 15 | 2022 |
| Draft genome sequences of two isolates of the yeast Kazachstania servazzii recovered from soil in Ireland L Faherty, C Lewis, M McElheron, N Garvey, R Duggan, B Shovlin, ... Microbiology Resource Announcements 8 (44), 10.1128/mra. 01257-19, 2019 | 9 | 2019 |
| Characterisation of the pro-inflammatory cytokine signature in severe COVID-19 HC Hawerkamp, AH Dyer, ND Patil, M McElheron, N O’Dowd, ... Frontiers in Immunology 14, 1170012, 2023 | 6 | 2023 |
| 177 GENOME-WIDE ASSOCIATION ANALYSIS OF THE FRAILTY PHENOTYPE IN UK BIOBANK HIGHLIGHTS CARDIOMETABOLIC AND AUTOIMMUNE SIGNATURES IN AGEING M McElheron, R Romero-Ortuno, RA Kenny, A O'Halloran, N Bourke Age and Ageing 51 (Supplement_3), afac218. 151, 2022 | 1 | 2022 |
| Disease-Modifying Treatments for Multiple Sclerosis Affect Measures of Cellular Immune Responses to EBNA-1 Peptides L Dungan, J Dunne, M Savio, M Kalaszi, M McElheron, Y Lynagh, ... Neurology: Neuroimmunology & Neuroinflammation 11 (3), e200217, 2024 | | 2024 |
| Moving from “vulnerability” to “inter-individual variability” in defining a place for the biology of ageing in geriatric medicine AH Dyer, H Dolphin, M McElheron, NM Bourke, SP Kennelly European Geriatric Medicine 14 (6), 1413-1414, 2023 | | 2023 |
| Optimal LC-MS metabolomic profiling reveals emergent changes to monocyte metabolism in response to lipopolysaccharide E Leacy, I Batten, L Sanelli, M McElheron, G Brady, MA Little, H Khouri Frontiers in Immunology 14, 1116760, 2023 | | 2023 |
| Exploration into epigenetic ageing in ANCA-associated vasculitis I Batten, M McElheron, C Conway, MW Robinson, MA Little, NM Bourke EUROPEAN JOURNAL OF IMMUNOLOGY 52, 105-105, 2022 | | 2022 |
| 16 SARS-COV-2 INFECTION AND VACCINATION PATTERNS DETERMINE LONG-TERM ANTIBODY RESPONSES IN NURSING HOME RESIDENTS: DATA FROM NH-COVAIR A Dyer, C Noonan, C Reddy, L Garcia, I Batten, M McElheron, N Roche, ... Age and Ageing 51 (Supplement_3), afac218. 012, 2022 | | 2022 |
| Does historical viral exposure influence COVID-19 disease trajectory in older adults? A machine learning analysis of comprehensive viral epitope screening (VirScan) in the … M McElheron, I Batten, E Laird, S Pellau, B McSharry, M Little, M White, ... European Journal of Immunology, 53-53, 2022 | | 2022 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths C Danish, CHG Effort, CS Clinicians, C HealthCare, CVC Cohort, ... Science immunology 6 (62), eabl4340, 2021 | | 2021 |
